In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

Unverified data about events after vaccinations is not evidence that the vaccine caused the event, as suggested in social ...

Vaccines for children can help protect against severe illness, hospitalization, and death from COVID. Children aged 6 months ...

The Centers for Disease Control and Prevention's (CDC's) 2024-2025 COVID-19 vaccine immunization schedule advises, in the ...

Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

The options include the mRNA vaccines from Pfizer/BioNTech and Moderna — the vaccines that ... the federal government has not ...

The Centers for Disease Control and Prevention now recommends that people ages 65 and up and those with weakened immune ...

Summer's rise in COVID-19 cases led to the approval of updated versions of vaccinations targeting recent strains for the 2024 ...

Here's what they found. Pfizer-BioNTech: The Pfizer-BioNTech vaccine was the first COVID vaccine to receive FDA Emergency Use Authorization from the Food and Drug Administration back in December 2020.